A B S T R A C T PurposeConformal radiation therapy (CRT) aims to limit the highest radiation dose to the tissue volume at risk while sparing surrounding normal tissues. This study investigated whether treatment of childhood ependymoma with CRT would preserve cognitive function. Academic competence was chosen as the primary outcome measure given it is a measure of applied cognitive abilities in a child's natural setting.
Patients and MethodsEighty-seven pediatric patients diagnosed with ependymoma received CRT in which doses ranging from 54.0 to 59.4 Gy were prescribed to the postoperative tumor bed with a 10-mm clinical target volume margin. Cognitive testing was conducted at the start of CRT, 6 months, and annually after the start of CRT. The median length of follow-up was 59.6 months. Academic testing included subtests from the Wechsler Individual Achievement Test (WIAT) and the Achenbach Child Behavior Checklist.
ResultsLinear mixed models with random coefficients revealed a modest but significant decline in reading scores during follow-up (WIAT slope estimate ÏȘ0.064 Ïź 0.028 points/month; P Ï .026). Math and spelling performance remained stable. Supratentorial tumor location and multiple surgeries were predictive of worse reading performance at CRT baseline. Male sex, longer symptomatic interval, pre-CRT chemotherapy, pre-existing endocrine deficiencies, hydrocephalus, and younger age at CRT (Ïœ 5 years) were predictive of a significant decline in reading scores over time.
ConclusionCRT may result in better long-term cognitive outcomes when compared to conventional radiation therapy approaches. Reading appears more vulnerable than other academic skills and may decline over time despite stable intellectual functioning.
J Clin Oncol 26:3965-3970. © 2008 by American Society of Clinical Oncology
INTRODUCTIONEpendymoma is the third most common CNS tumor of childhood, affecting approximately 300 individuals under 19 years of age in the United States annually.1 Successful management typically includes surgery and postoperative radiation therapy. Treatment advances have lead to improved survival rates with 3-year progression-free survival estimates as high as 75%.2 As survival rates improve, an increased understanding of the long-term functional impact of treatment becomes imperative.Children who receive radiation for ependymoma are at increased risk for impairments in endocrine, neurologic, and cognitive functioning. Findings of adverse cognitive outcomes typically come from studies investigating whole-brain irradiation at 18, 24, and 36 Gy, doses customarily used in the treatment of medulloblastoma and acute lymphoblastic leukemia. 4 There is evidence to suggest total radiation dose and volume of irradiated brain play a significant role in neurocognitive outcome, with lower doses of cranial radiation associated with less intellectual impairment. 5,6 Thus, there is strong rationale for reduction in radiation dose and volume when appropriate tumor control can be maintained for localized pediatric brain tumors.Conforma...